These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

603 related items for PubMed ID: 20433216

  • 1. Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.
    Jacobson Vann JC, Christofferson S, Humble CG, Wegner SE, Feaganes JR, Trygstad TK.
    J Manag Care Pharm; 2010 May; 16(4):250-63. PubMed ID: 20433216
    [Abstract] [Full Text] [Related]

  • 2. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.
    Ramser KL, Sprabery LR, Hamann GL, George CM, Will A.
    J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274
    [Abstract] [Full Text] [Related]

  • 3. Proton-pump inhibitor utilization associated with the change to nonpreferred formulary status for esomeprazole in the TRICARE formulary.
    Linton A, Bacon T, Peterson M.
    J Manag Care Pharm; 2009 May; 15(1):42-54. PubMed ID: 19125549
    [Abstract] [Full Text] [Related]

  • 4. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
    Johnson JT, Neill KK, Davis DA.
    J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
    [Abstract] [Full Text] [Related]

  • 5. Examination of why some community pharmacists do not provide 72-hour emergency prescription drugs to Medicaid patients when prior authorization is not available.
    Shepherd MD.
    J Manag Care Pharm; 2013 Sep; 19(7):523-33. PubMed ID: 23964613
    [Abstract] [Full Text] [Related]

  • 6. Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid Program.
    Simeone JC, Marcoux RM, Quilliam BJ.
    J Manag Care Pharm; 2010 Jun; 16(5):317-28. PubMed ID: 20518584
    [Abstract] [Full Text] [Related]

  • 7. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
    Barnett MJ, Frank J, Wehring H, Newland B, VonMuenster S, Kumbera P, Halterman T, Perry PJ.
    J Manag Care Pharm; 2009 Jun; 15(1):18-31. PubMed ID: 19125547
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
    Perera PN, Guy MC, Sweaney AM, Boesen KP.
    J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
    [Abstract] [Full Text] [Related]

  • 9. Retrospective analysis of community pharmacists' recommendations in the North Carolina Medicaid medication therapy management program.
    Michaels NM, Jenkins GF, Pruss DL, Heidrick JE, Ferreri SP.
    J Am Pharm Assoc (2003); 2010 Jun; 50(3):347-53. PubMed ID: 20452907
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of product switching after a state Medicaid program began covering loratadine OTC 1 year after market availability.
    Trygstad TK, Hansen RA, Wegner SE.
    J Manag Care Pharm; 2006 Mar; 12(2):108-20. PubMed ID: 16515369
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacy participation and claim characteristics in the Wisconsin Medicaid Pharmaceutical Care Program from 1996 to 2007.
    Look KA, Mott DA, Leedham RK, Kreling DH, Hermansen-Kobulnicky CJ.
    J Manag Care Pharm; 2012 Mar; 18(2):116-28. PubMed ID: 22380471
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Addition of generic medication vouchers to a pharmacist academic detailing program: effects on the generic dispensing ratio in a physician-hospital organization.
    Bhargava V, Greg ME, Shields MC.
    J Manag Care Pharm; 2010 Mar; 16(6):384-92. PubMed ID: 20635829
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.